Latest Period
Q2 2026
Security Snapshot
FILANA THERAPEUTICS, INC. - Common Stock (FLNA) Institutional Ownership
CUSIP: 14817C107
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
82
Shares (Excl. Options)
12,678,171
Price
$1.19
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- FLNA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 12,678,171
- Total 13F value
- $15,087,375
- Portfolio coverage rank
- 0%
- Share change
- -940,579
- Value change
- -$1,525,556
- Number of holders
- 82
- Shares outstanding
- 48,331,225
- SEC-reported price per share
- $1.31
- Insider filing price
- $1.31
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FLNA - FILANA THERAPEUTICS, INC. - Common Stock is tracked under CUSIP 14817C107.
- 82 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 99 to 82 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $23,061,084 to $15,087,375.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 82 institutions filings for Q2 2026.
Security key
14817C107
Latest holder period
Q2 2026
13F holders
82
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
FLNA full holder history
FILANA THERAPEUTICS, INC. SEC filings
FILANA THERAPEUTICS, INC. company facts
FILANA THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14817C107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
FLNA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nachtrab Matthew | 4.7% | $3,560,189 | 2,267,636 | Nachtrab Matthew | 16 Aug 2024 | |||
| VANGUARD GROUP INC | 4.5% | $3,927,830 | 2,170,072 | The Vanguard Group | 30 Jun 2025 | |||
| BlackRock, Inc. | 3.2% | $2,797,129 | 1,545,375 | BlackRock, Inc. | 30 Jun 2025 |
As of 30 Jun 2026, 82 institutional investors reported holding 12,678,171 shares of FILANA THERAPEUTICS, INC. - Common Stock (FLNA). This represents 26% of the company’s total 48,331,225 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
25%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 1,974,981 | +2.3% | 0% | $2,350,227 |
| TWO SIGMA INVESTMENTS, LP | 3.5% | 1,711,358 | -14% | 0% | $2,036,516 |
| MARSHALL WACE, LLP | 3.3% | 1,597,548 | -21% | 0% | $1,901,084 |
| BlackRock, Inc. | 3% | 1,453,561 | +2.8% | 0% | $1,729,737 |
| GOLDMAN SACHS GROUP INC | 1.4% | 668,792 | +1518% | 0% | $795,862 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 615,510 | +3.2% | 0% | $732,736 |
| D. E. Shaw & Co., Inc. | 1% | 485,025 | -13% | 0% | $577,180 |
| GMT Capital Corp | 0.93% | 450,100 | 0% | 0.03% | $535,619 |
| RENAISSANCE TECHNOLOGIES LLC | 0.81% | 389,601 | +19% | 0% | $463,625 |
| Squarepoint Ops LLC | 0.66% | 318,380 | 0% | $378,872 | |
| VANGUARD FIDUCIARY TRUST CO | 0.65% | 315,889 | +15% | 0% | $375,908 |
| ACADIAN ASSET MANAGEMENT LLC | 0.61% | 295,059 | +3.8% | 0% | $350,000 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.6% | 292,017 | -35% | 0% | $347,501 |
| GSA CAPITAL PARTNERS LLP | 0.56% | 269,410 | +24% | 0.02% | $321,000 |
| GROUP ONE TRADING LLC | 0.5% | 244,008 | -19% | 0.01% | $290,370 |
| STATE STREET CORP | 0.43% | 209,105 | -13% | 0% | $248,835 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.27% | 132,597 | -0.07% | 0% | $157,790 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.27% | 132,298 | -3.4% | 0% | $157,435 |
| FEDERATED HERMES, INC. | 0.25% | 119,952 | +4.2% | 0% | $142,743 |
| NORTHERN TRUST CORP | 0.24% | 114,322 | -23% | 0% | $136,043 |
| SIMPLEX TRADING, LLC | 0.21% | 99,879 | -29% | 0% | $118,856 |
| STIFEL FINANCIAL CORP | 0.16% | 75,000 | 0% | $89,250 | |
| XTX Topco Ltd | 0.13% | 64,614 | +94% | 0% | $76,891 |
| JANE STREET GROUP, LLC | 0.12% | 58,981 | -74% | 0% | $70,187 |
| Verition Fund Management LLC | 0.1% | 46,870 | +23% | 0% | $55,775 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 12,678,171 | $15,087,375 | -$1,525,556 | $1.19 | 82 |
| 2026 Q1 | 13,646,372 | $23,061,084 | -$584,591 | $1.69 | 99 |
| 2025 Q4 | 13,806,828 | $27,336,180 | -$753,360 | $1.98 | 105 |
| 2025 Q3 | 13,778,326 | $40,074,441 | +$5,040,034 | $2.91 | 101 |
| 2025 Q2 | 12,246,863 | $22,166,624 | -$6,209,960 | $1.81 | 96 |
| 2025 Q1 | 15,768,881 | $23,653,533 | -$3,650,996 | $1.50 | 114 |
| 2024 Q4 | 17,411,806 | $41,096,950 | -$26,811,358 | $2.36 | 135 |
| 2024 Q3 | 14,006,298 | $412,343,524 | +$21,408,686 | $29.43 | 159 |
| 2024 Q2 | 13,297,542 | $164,180,761 | +$20,340,671 | $12.35 | 140 |
| 2024 Q1 | 11,593,879 | $235,338,414 | -$49,008,344 | $20.29 | 141 |
| 2023 Q4 | 13,929,974 | $313,474,831 | +$20,318,834 | $22.51 | 150 |
| 2023 Q3 | 12,909,705 | $214,797,641 | +$17,325,070 | $16.64 | 136 |
| 2023 Q2 | 11,697,131 | $286,735,353 | -$6,324,947 | $24.52 | 150 |
| 2023 Q1 | 11,914,630 | $287,373,528 | +$15,058,161 | $24.12 | 140 |
| 2022 Q4 | 11,254,249 | $332,457,243 | +$2,217,261 | $29.54 | 146 |
| 2022 Q3 | 10,511,058 | $439,522,416 | +$28,422,554 | $41.82 | 164 |
| 2022 Q2 | 9,860,019 | $277,264,167 | -$22,312,348 | $28.12 | 136 |
| 2022 Q1 | 10,487,576 | $389,768,314 | -$39,764,775 | $37.14 | 147 |
| 2021 Q4 | 11,534,283 | $504,052,860 | -$49,487,683 | $43.70 | 160 |
| 2021 Q3 | 12,113,852 | $751,991,955 | +$67,636,793 | $62.08 | 169 |
| 2021 Q2 | 10,434,065 | $891,498,117 | +$48,315,268 | $85.44 | 163 |
| 2021 Q1 | 10,158,803 | $456,594,941 | +$91,884,258 | $44.95 | 116 |
| 2020 Q4 | 9,404,804 | $64,135,775 | +$15,501,397 | $6.82 | 70 |
| 2020 Q3 | 6,699,572 | $77,113,513 | +$9,133,318 | $11.51 | 63 |
| 2020 Q2 | 5,994,033 | $18,463,673 | -$2,167,955 | $3.08 | 47 |